Skip to main content

SB 435 — Maryland

Public Health - Medetomidine and Xylazine Consumer Protection Act

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • SB 435 is a bill in the Maryland Senate, 2026 session, introduced January 30, 2026.
  • Sponsored by Folden.
  • Current status: introduced.
  • Most recent action (April 13, 2026): Motion Laid Over (Senator Ready) Adopted.
  • Subjects: Age, Comptroller, Consumer Protection, Controlled Dangerous Substances, Drugs, Health.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Folden

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House of Delegates, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate First Reading Finance
  2. Senate Hearing 2/11 at 2:00 p.m.
  3. Senate Favorable with Amendments Report by Finance
  4. Senate Favorable with Amendments {
  5. Senate Motion Laid Over (Senator Ready) Adopted Latest

Source: Open States. Last checked November 14, 2026. How we keep this accurate ›